TrialJournal for immunotherapy of cancer2020

Vaccination against RhoC induces long-lasting immune responses in patients with prostate cancer: results from a phase I/II clinical trial.

Juliane Schuhmacher et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.